Publication | Closed Access

CELLTOP Clinical Trial: First Report From a Phase 1 Trial of Autologous Adipose Tissue–Derived Mesenchymal Stem Cells in the Treatment of Paralysis Due to Traumatic Spinal Cord Injury

Tissue EngineeringCell TherapyCelltop Clinical TrialStem Cell BiologyCellular TherapiesOrthopaedic SurgeryRegenerative MedicineStem CellsCell TransplantationSpinal Cord InjuryStem Cell TherapiesFirst ReportCell BiologyMesenchymal Stem CellStem Cell EngineeringSpinal TraumaStem Cell ResearchStem-cell TherapyMedicinePhase 1